지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
Clinical and Molecular Hepatology
2020 .01
Performance comparisons of two biomarker-based panels for early diagnosis of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multi-institutional case-control analysis
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
Clinical and Molecular Hepatology
2023 .04
Effect of Korean Red Ginseng in chronic liver disease
Journal of Ginseng Research
2017 .10
A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2022 .07
Personalized medicine in nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2022 .10
Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma
Clinical and Molecular Hepatology
2023 .02
Sarcopenia as a Novel Risk Factor for Nonalcoholic Fatty Liver Disease
Journal of Obesity & Metabolic Syndrome
2020 .01
The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
The Impact of Body Composition on the Prognosis of Nonalcoholic Fatty Liver Disease
Gut and Liver
2024 .07
Surveillance for hepatocellular carcinoma: It is time to move forward
Clinical and Molecular Hepatology
2022 .10
The growing burden of non-alcoholic fatty liver disease on mortality
Clinical and Molecular Hepatology
2023 .04
Implications of comorbidities in nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease
Gut and Liver
2019 .01
Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
Clinical and Molecular Hepatology
2022 .10
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2021 .01
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
Clinical and Molecular Hepatology
2023 .04
Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”
Clinical and Molecular Hepatology
2023 .01
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
Clinical and Molecular Hepatology
2023 .02
Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults
Clinical and Molecular Hepatology
2022 .07
0